GNAS Methylation-Specific MLPA

Test Information

GNAS Methylation-Specific MLPA is a molecular test used to detect copy number variants and methylation abnormalities within the GNAS complex locus on chromosome 20q13.32.

Turnaround Time

3 weeks

CPT Code(s)

81479

Cost

$600

Genes

  • GNAS

Clinical Information

Pseudohypoparathyroidism (PHP) is caused by inactivation of GNAS. There are multiple PHP phenotypes resulting from GNAS inactivation, including PHP -Ia, -Ib, and –Ic. Additional phenotypes include pseudopseudohypoparathyroidism (PPHP), progressive osseous heteroplasia (POH), and osteoma cutis (OC). These disorders are associated with varying degrees of hormone resistance and skeletal abnormalities including short stature, subcutaneous ossifications, and brachydactyly. GNAS is an imprinted locus on chromosome 20q13.32 with a primary mechanism for GNAS inactivation resulting from methylation defects. Epigenetic inactivation of GNAS can occur through paternal uniparental disomy, isolated epimutations, and alterations in regulatory elements of GNAS or STX16. Disorders of GNAS inactivation are examples of disorders involving imprinted genes. Imprinted genes are only expressed from either the maternally or paternally derived member of a homologous chromosome pair. Disorders of GNAS inactivation are caused by the lack of expression of GNAS. PHP -Ia, -Ib, and –Ic are caused by inactivation of the maternal GNAS complex locus while PPHP, POH, and OC are caused by inactivation of the paternal GNAS complex locus.

Indications

Methylation testing and copy number status is useful to confirm the diagnosis. Further testing may be necessary to determine the etiology of the disorder. GNAS methylation is appropriate when a pathogenic variant is not identified on sequence analysis.

Methodology

A methylation sensitive multiplex ligation-dependent probe amplification (MLPA) assay is used to determine methylation status at 20q13.32 as well as any copy number variants in this region.

Detection

10-60% of probands with a disorder of GNAS Inactivation have a diagnostic change detectable by methylation analysis. This increases to almost 100% for probands with PHP-Ib.

Specimen Requirements

The preferred sample type is 3-5 ml of peripheral blood collected in an EDTA (purple top) tube. Extracted DNA is also accepted for this test.

Transport Instructions

The specimen should be kept at room temperature and delivered via overnight shipping. If shipment is delayed by one or two days, the specimen should be refrigerated and shipped at room temperature. Do not freeze the specimen. Samples collected on Friday can be safely designated for Monday delivery.

Have Questions? Need Support?

Call our laboratory at 1-800-473-9411 or contact one of our Laboratory Genetic Counselors for assistance.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC

Meet Reggie Roper

Reggie has been part of the GGC family for over 18 years. He has short stature, webbing of his hands, pulmonary stenosis, seizures and hydrocephalus along with developmental delay. He carried an initial diagnosis of cardiofaciocutaneous (CFC) syndrome; however, as genetic testing advanced, GGC made the diagnosis of Noon...

In The News